AstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.
MarketWatch· Steve Goldstein· Aug 3, 2026 · 11:02 AM
AstraZeneca shares were slumping while Bristol-Myers Squibb was jumping on Monday on reported deal talks. But the big question is why these two pharmaceutical giants would want to come together in the first place.
This is a summary. Read the complete story at MarketWatch below.
Read full article at MarketWatchRelated Stories
marketsabout 7 hours ago
Why Western Digital and Seagate are seeing big stock drops today
Investors are worried that Toshiba will boost its production of a key AI storage product, potentially hurting the strong pricing power that Western Digital and Seagate currently enjoy.
MarketWatch
marketsabout 8 hours ago
Tesla sold a lot more EVs than Wall Street expected, and the stock is surging
EV giant Tesla had the best three-month period for vehicle sales this year, but it was less than a year ago.
MarketWatch
marketsabout 8 hours ago
Falling wages, soaring energy prices and inflation: It’s beginning to look a lot like the 1970s
Is it time to dust off the financial playbook from that dismal decade?
MarketWatch